Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not? Andrea RubboliDan Atar Commentary 13 July 2021 Pages: 113 - 115
The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative Review Haneul ChoXiao-Xiao ZhaoWeon Kim Review Article 21 June 2021 Pages: 117 - 125
The Current Role of Clevidipine in the Management of Hypertension Bo XuZhen ChenGaorui Tang Review Article 02 September 2021 Pages: 127 - 139
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice Maddalena RossiEnrico FabrisGianfranco Sinagra Review Article Open access 13 September 2021 Pages: 141 - 155
Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation and Concomitant Liver Cirrhosis: A Systematic Review and Meta-Analysis Zhi-Yan LeeBoon-Hao SuahChing-Hui Sia Systematic Review 19 May 2021 Pages: 157 - 165
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis Chia Siang KowSyed Shahzad Hasan Systematic Review 03 August 2021 Pages: 167 - 181
Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis Qingtao HouCaishuang PangYuqin Chen Original Research Article 23 July 2021 Pages: 183 - 193
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial Daniel M. F. ClaassensPim W. M. van DorstCornelis Boersma Original Research Article 07 September 2021 Pages: 195 - 206
Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries Faye L. NorbyPamela L. LutseyAaron R. Folsom Original Research Article 11 October 2021 Pages: 207 - 217
Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use Yahiya Y. Syed Adis Drug Q&A Open access 08 March 2022 Pages: 219 - 230
